1. Home
  2. FOR vs SVRA Comparison

FOR vs SVRA Comparison

Compare FOR & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forestar Group Inc

FOR

Forestar Group Inc

HOLD

Current Price

$29.20

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Savara Inc.

SVRA

Savara Inc.

HOLD

Current Price

$5.75

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOR
SVRA
Founded
2005
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
2007
2009

Fundamental Metrics

Financial Performance
Metric
FOR
SVRA
Price
$29.20
$5.75
Analyst Decision
Buy
Buy
Analyst Count
3
9
Target Price
$32.67
$7.33
AVG Volume (30 Days)
126.8K
1.6M
Earning Date
04-21-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.93
N/A
Revenue
$1,662,400,000.00
N/A
Revenue This Year
$0.34
N/A
Revenue Next Year
$7.73
$430.87
P/E Ratio
$31.20
N/A
Revenue Growth
10.14
N/A
52 Week Low
$20.79
$1.98
52 Week High
$30.74
$7.01

Technical Indicators

Market Signals
Indicator
FOR
SVRA
Relative Strength Index (RSI) 60.14 66.88
Support Level $23.88 $4.77
Resistance Level $30.74 $6.15
Average True Range (ATR) 0.85 0.26
MACD 0.06 0.07
Stochastic Oscillator 75.04 87.55

Price Performance

Historical Comparison
FOR
SVRA

About FOR Forestar Group Inc

Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. The company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.

About SVRA Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Share on Social Networks: